SMC Consultation for Benlysta |
Welcome to LUPUS UK's Survey
LUPUS UK is producing a report to submit to the Scottish Medicines Consortium (SMC) - www.scottishmedicines.org.uk - as part of a consultation discussing whether Benlysta (belimumab) should be available to be used by lupus patients who meet the requirements for the treatment.
An important part of this submission will include views from people affected by lupus about the condition, their experiences with currently available treatments and their expectations from future treatments.
We would be very grateful if you could take the time to complete this questionnaire. Any responses used in the report will be kept anonymous. If you are happy to submit your email address at the end of the survey it will allow us to contact you if we need any further information about any of your responses. Your email address will not be used for any other purpose.
An important part of this submission will include views from people affected by lupus about the condition, their experiences with currently available treatments and their expectations from future treatments.
We would be very grateful if you could take the time to complete this questionnaire. Any responses used in the report will be kept anonymous. If you are happy to submit your email address at the end of the survey it will allow us to contact you if we need any further information about any of your responses. Your email address will not be used for any other purpose.
The survey should take approximately 10-20 minutes to complete. Thank you for your time.